High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective

被引：34
|
作者：
Yoshioka, Yasuo [1 ]
Suzuki, Osamu [1 ]
Otani, Yuki [1 ]
Yoshida, Ken [2 ]
Nose, Takayuki [3 ]
Ogawa, Kazuhiko [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka 5650871, Japan
[2] Osaka Med Coll, Dept Radiol, Osaka, Japan
[3] Tama Nagayama Hosp, Nippon Med Sch, Dept Radiat Oncol, Tokyo, Japan
来源：
JOURNAL OF CONTEMPORARY BRACHYTHERAPY | 2014年 / 6卷 / 01期
关键词：
prostate cancer; radiotherapy; high-dose-rate (HDR) brachytherapy; monotherapy; hypofractionation; RATE INTERSTITIAL BRACHYTHERAPY; RATE AFTERLOADING BRACHYTHERAPY; HDR BRACHYTHERAPY; CATHETER MOVEMENT; PHASE-II; FEASIBILITY REPORT; ALPHA/BETA RATIO; FRACTIONS; TRIAL; RECOMMENDATIONS;
D O I：
10.5114/jcb.2014.42026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
High-dose-rate (HDR) brachytherapy as monotherapy is a comparatively new brachytherapy procedure for prostate cancer. Although clinical results are not yet mature enough, it is a highly promising approach in terms of potential benefits for both radiation physics and radiobiology. In this article, we describe our technique for monotherapeutic HDR prostate brachytherapy, as well as the rationale and theoretical background, with educational intent.
引用
收藏
页码：91 / 98
页数：8
相关论文
共 50 条
  • [1] High-dose-rate brachytherapy as monotherapy for prostate cancer
    Demanes, D. Jeffrey
    Ghilezan, Michel I.
    [J]. BRACHYTHERAPY, 2014, 13 (06) : 529 - 541
  • [2] High-dose-rate brachytherapy as monotherapy in prostate cancer
    Rebecca Kelsey
    [J]. Nature Reviews Urology, 2015, 12 (7) : 359 - 359
  • [3] High-Dose-Rate Interstitial Brachytherapy as Monotherapy in Prostate Cancer Patients
    Kazberuk, D.
    Filipowski, T.
    Szmigiel-Trzcinska, A.
    Niksa, M.
    Hempel, D.
    Pancewicz-Janczuk, B.
    Nowik, W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S448 - S448
  • [4] The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
    Yoshioka, Yasuo
    Yoshida, Ken
    Yamazaki, Hideya
    Nonomura, Norio
    Ogawa, Kazuhiko
    [J]. JOURNAL OF RADIATION RESEARCH, 2013, 54 (05) : 781 - 788
  • [5] Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
    Contreras, Jessika A.
    Wilder, Richard B.
    Mellon, Eric A.
    Strom, Tobin J.
    Fernandez, Daniel C.
    Biagioli, Matthew C.
    [J]. INTERNATIONAL BRAZ J UROL, 2015, 41 (01): : 40 - 45
  • [6] High-dose-rate brachytherapy as monotherapy for prostate cancer: Osaka University experience
    Yoshioka, Y.
    Oh, R. J.
    Konishi, K.
    Suzuki, O.
    Sumida, I.
    Shiomi, H.
    Yamazaki, H.
    Nonomura, N.
    Okuyama, A.
    Inoue, T.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 243 - 243
  • [7] What is the α/β ratio for prostate cancer?: Rationale for hypofractionated high-dose-rate brachytherapy
    Duchesne, GM
    Peters, LJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (04): : 747 - 748
  • [8] Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
    Barnes, Justin
    Kennedy, William R.
    Fischer-Valuck, Benjamin W.
    Baumann, Brian C.
    Michalski, Jeff M.
    Gay, Hiram A.
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2019, 11 (04) : 320 - 328
  • [9] High-dose-rate brachytherapy as monotherapy for prostate cancer: 5-year results
    Solodkiy, V. A.
    Pavlov, A. Yu
    Tsybulskii, A. D.
    Dzidzaria, A. G.
    Sorokin, A. S.
    Mirzakhanov, R., I
    [J]. ONKOUROLOGIYA, 2022, 18 (01): : 58 - 69
  • [10] High-dose-rate brachytherapy as a monotherapy in the treatment of low and intermediate risk prostate cancer
    Ghadjar, P.
    Keller, T.
    Rentsch, C. A.
    Isaak, B.
    Behrensmeier, F.
    Stroux, A.
    Thalmann, G. N.
    Aebersold, D. M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 43 - 44
12345